+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Global Cholera Vaccines Market by Type (Inactivated Vaccine, Live Attenuated Vaccine), Method of Administration (Injectable Vaccines, Oral Vaccines), End User, Age Group - Forecast 2024-2030- Product Image
Global Cholera Vaccines Market by Type (Inactivated Vaccine, Live Attenuated Vaccine), Method of Administration (Injectable Vaccines, Oral Vaccines), End User, Age Group - Forecast 2024-2030- Product Image
Sale

Global Cholera Vaccines Market by Type (Inactivated Vaccine, Live Attenuated Vaccine), Method of Administration (Injectable Vaccines, Oral Vaccines), End User, Age Group - Forecast 2024-2030

  • PDF Icon

    Report

  • 191 Pages
  • May 2024
  • Region: Global
  • 360iResearch™
  • ID: 5968086
UP TO OFF until Dec 31st 2024
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Cholera Vaccines Market size was estimated at USD 286.42 million in 2023, USD 307.02 million in 2024, and is expected to grow at a CAGR of 7.32% to reach USD 469.83 million by 2030.

Cholera vaccines are biological preparations designed to protect individuals from cholera, a severe diarrheal illness caused by the Vibrio cholerae bacteria. These vaccines stimulate the body's immune response, enabling it to quickly recognize and combat the cholera bacteria if exposed. There are several types of cholera vaccines available, including both oral and injectable forms, each with varying degrees of effectiveness and duration of immunity. The use of cholera vaccines has expanded considerably owing to the global increase in travel to areas where cholera is endemic, which has heightened the need for preventive measures among travelers.

Further, growing awareness and international support for global health initiatives have increased funding and logistical support for vaccination programs in vulnerable regions. However, the deployment of cholera vaccines faces several challenges. Logistical difficulties in distributing and administering vaccines in remote or resource-limited areas hinder widespread coverage. Additionally, the variability in vaccine-induced immunity, which can be influenced by factors such as age and the presence of pre-existing immunity, complicates the measurement of vaccine effectiveness in different populations. Despite these challenges, advances in vaccine technology, such as the development of single-dose vaccines or temperature-stable formulations, could significantly improve the practicality and effectiveness of vaccination campaigns. Moreover, integrating cholera vaccination programs with other public health initiatives could enhance overall disease control and promote more sustainable health improvements in affected regions.

Regional Insights

The cholera vaccine market exhibits distinct characteristics across various global regions, shaped by public health needs and socio-economic conditions. In America, there is demand among travelers and certain immigrant communities from cholera-endemic regions. Further, robust healthcare and sanitation systems across the region facilitate cholera vaccination programs. Europe has a significant adoption of cholera vaccines, majorly among travelers and military personnel deployed to endemic regions. The Middle East and Africa face higher risks and incidences of cholera, primarily attributed to poor sanitation and inadequate access to clean water, generating a need for cholera vaccines.

Asia-Pacific observes a significant need for the cholera vaccine owing to higher prevalence rates in South and Southeast Asia. Countries such as India and Bangladesh are heavily impacted by cholera, largely driving the need in the region. The increasing awareness and government initiatives to control cholera outbreaks also support the steady consumption of these vaccines.

Market Trends by Segment

  • Type: Higher adoption of attenuated vaccines owing to their ability to stimulate strong immune responses
  • End User: Growing significance of Government vaccination programs, focusing on educating people about cholera prevention methods and the importance of vaccination

Industry Insights

  • Market Dynamics
  • Market Disruption Analysis
  • Porter’s Five Forces Analysis
  • Value Chain & Critical Path Analysis
  • Pricing Analysis
  • Technology Analysis
  • Patent Analysis
  • Trade Analysis
  • Regulatory Framework Analysis
  • FPNV Positioning Matrix
  • Market Share Analysis
  • Strategy Analysis and Recommendations

Recent Developments

Strategic Technology Transfer in Cholera Vaccination: A Partnership Between IVI and Biological E. Limited

South Korea's International Vaccine Institute (IVI) has initiated a technology transfer to Biological E. Limited (BE), an Indian vaccine and pharmaceutical company. This collaboration involves IVI providing BE with the necessary technical information, know-how, and materials to manufacture the simplified oral cholera vaccine (OCV-S) in India. This partnership intends to enhance the availability of affordable cholera vaccines for both the Indian market and globally.

Strategic Collaboration for Cholera Vaccine Production between GC Biopharma and Eubiologics

GC Biopharma, a South Korean biopharmaceutical company, has entered into a memorandum of understanding with Eubiologics to collaboratively produce the oral cholera vaccine, Euvichol. Under this agreement, Eubiologics will manage the bulk manufacturing phase of the vaccine, while GC Biopharma will handle the packaging tasks, including the bottling of the vaccine into vials, ensuring a streamlined process for vaccine supply.

TechInvention Introduces Innovative Cholera Vaccine Packaging in India with Eubiologics Partnership

Mumbai-based TechInvention Lifecare, in collaboration with South Korea's Eubiologics Co., has introduced Euvichol-Plus, an oral cholera vaccine encased in a low-density polyethylene (LDPE) unidose pack. This innovative packaging solution addresses several issues associated with traditional glass vials, including risks of breakage and challenges in storage, transportation, handling, and disposal.

Key Company Profiles

The report delves into recent significant developments in the Cholera Vaccines Market, highlighting leading vendors and their innovative profiles. These include Astellas Pharma Inc., Beijing Minhai Biological Technology Co., Ltd., Bharat Biotech Ltd., Bio-Manguinhos, Biological E Ltd, BioVac by Ceva Santé Animale, Emergent BioSolutions Inc., GlaxoSmithKline plc, Haffkine Bio-Pharmaceutical Corporation Ltd, Incepta Pharmaceuticals Ltd., Merck & Co. Inc, Panacea Biotec Ltd, Sanofi S.A., SK Inc., Techinvention Lifecare Pvt. Ltd., and Valneva SE.

This research report offers invaluable insights into various crucial aspects of the Cholera Vaccines Market:

  1. Market Penetration: This section thoroughly overviews the current market landscape, incorporating detailed data from key industry players.
  2. Market Development: The report examines potential growth prospects in emerging markets and assesses expansion opportunities in mature segments.
  3. Market Diversification: This includes detailed information on recent product launches, untapped geographic regions, recent industry developments, and strategic investments.
  4. Competitive Assessment & Intelligence: An in-depth analysis of the competitive landscape is conducted, covering market share, strategic approaches, product range, certifications, regulatory approvals, patent analysis, technology developments, and advancements in the manufacturing capabilities of leading market players.
  5. Product Development & Innovation: This section offers insights into upcoming technologies, research and development efforts, and notable advancements in product innovation.

Additionally, the report addresses key questions to assist stakeholders in making informed decisions:

  1. What is the current market size and projected growth?
  2. Which products, segments, applications, and regions offer promising investment opportunities?
  3. What are the prevailing technology trends and regulatory frameworks?
  4. What is the market share and positioning of the leading vendors?
  5. What revenue sources and strategic opportunities do vendors in the market consider when deciding to enter or exit?

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary4. Market Overview
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Rising number of cholera cases across the globe
5.1.1.2. Supportive government promotional campaigns for cholera vaccination
5.1.2. Restraints
5.1.2.1. High cost of vaccine development coupled with issues of product shortages
5.1.3. Opportunities
5.1.3.1. Developments in recombinant DNA technology and cell-based production systems
5.1.3.2. Innovations in packaging and storage solutions for cholera vaccines
5.1.4. Challenges
5.1.4.1. Limited availability of skilled healthcare professionals worldwide
5.2. Market Segmentation Analysis
5.2.1. Type: Higher adoption of attenuated vaccines owing to their ability to stimulate strong immune responses
5.2.2. End User: Growing significance of Government vaccination programs, focusing on educating people about cholera prevention methods and the importance of vaccination
5.3. Market Disruption Analysis
5.4. Porter’s Five Forces Analysis
5.4.1. Threat of New Entrants
5.4.2. Threat of Substitutes
5.4.3. Bargaining Power of Customers
5.4.4. Bargaining Power of Suppliers
5.4.5. Industry Rivalry
5.5. Value Chain & Critical Path Analysis
5.6. Pricing Analysis
5.7. Technology Analysis
5.8. Patent Analysis
5.9. Trade Analysis
5.10. Regulatory Framework Analysis
6. Cholera Vaccines Market, by Type
6.1. Introduction
6.2. Inactivated Vaccine
6.3. Live Attenuated Vaccine
7. Cholera Vaccines Market, by Method of Administration
7.1. Introduction
7.2. Injectable Vaccines
7.3. Oral Vaccines
8. Cholera Vaccines Market, by End User
8.1. Introduction
8.2. Government Vaccination Programs
8.3. Hospitals & Clinics
9. Cholera Vaccines Market, by Age Group
9.1. Introduction
9.2. Adults
9.3. Children
10. Americas Cholera Vaccines Market
10.1. Introduction
10.2. Argentina
10.3. Brazil
10.4. Canada
10.5. Mexico
10.6. United States
11. Asia-Pacific Cholera Vaccines Market
11.1. Introduction
11.2. Australia
11.3. China
11.4. India
11.5. Indonesia
11.6. Japan
11.7. Malaysia
11.8. Philippines
11.9. Singapore
11.10. South Korea
11.11. Taiwan
11.12. Thailand
11.13. Vietnam
12. Europe, Middle East & Africa Cholera Vaccines Market
12.1. Introduction
12.2. Denmark
12.3. Egypt
12.4. Finland
12.5. France
12.6. Germany
12.7. Israel
12.8. Italy
12.9. Netherlands
12.10. Nigeria
12.11. Norway
12.12. Poland
12.13. Qatar
12.14. Russia
12.15. Saudi Arabia
12.16. South Africa
12.17. Spain
12.18. Sweden
12.19. Switzerland
12.20. Turkey
12.21. United Arab Emirates
12.22. United Kingdom
13. Competitive Landscape
13.1. Market Share Analysis, 2023
13.2. FPNV Positioning Matrix, 2023
13.3. Competitive Scenario Analysis
13.3.1. Strategic Technology Transfer in Cholera Vaccination: A Partnership Between IVI and Biological E. Limited
13.3.2. Strategic Collaboration for Cholera Vaccine Production between GC Biopharma and Eubiologics
13.3.3. TechInvention Introduces Innovative Cholera Vaccine Packaging in India with Eubiologics Partnership
13.4. Strategy Analysis & Recommendation
14. Competitive Portfolio
14.1. Key Company Profiles
14.2. Key Product Portfolio
List of Figures
FIGURE 1. CHOLERA VACCINES MARKET RESEARCH PROCESS
FIGURE 2. CHOLERA VACCINES MARKET SIZE, 2023 VS 2030
FIGURE 3. GLOBAL CHOLERA VACCINES MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. GLOBAL CHOLERA VACCINES MARKET SIZE, BY REGION, 2023 VS 2030 (%)
FIGURE 5. GLOBAL CHOLERA VACCINES MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 6. CHOLERA VACCINES MARKET DYNAMICS
FIGURE 7. GLOBAL CHOLERA VACCINES MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
FIGURE 8. GLOBAL CHOLERA VACCINES MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL CHOLERA VACCINES MARKET SIZE, BY METHOD OF ADMINISTRATION, 2023 VS 2030 (%)
FIGURE 10. GLOBAL CHOLERA VACCINES MARKET SIZE, BY METHOD OF ADMINISTRATION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL CHOLERA VACCINES MARKET SIZE, BY END USER, 2023 VS 2030 (%)
FIGURE 12. GLOBAL CHOLERA VACCINES MARKET SIZE, BY END USER, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL CHOLERA VACCINES MARKET SIZE, BY AGE GROUP, 2023 VS 2030 (%)
FIGURE 14. GLOBAL CHOLERA VACCINES MARKET SIZE, BY AGE GROUP, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 15. AMERICAS CHOLERA VACCINES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 16. AMERICAS CHOLERA VACCINES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 17. UNITED STATES CHOLERA VACCINES MARKET SIZE, BY STATE, 2023 VS 2030 (%)
FIGURE 18. UNITED STATES CHOLERA VACCINES MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 19. ASIA-PACIFIC CHOLERA VACCINES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 20. ASIA-PACIFIC CHOLERA VACCINES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 21. EUROPE, MIDDLE EAST & AFRICA CHOLERA VACCINES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 22. EUROPE, MIDDLE EAST & AFRICA CHOLERA VACCINES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 23. CHOLERA VACCINES MARKET SHARE, BY KEY PLAYER, 2023
FIGURE 24. CHOLERA VACCINES MARKET, FPNV POSITIONING MATRIX, 2023
List of Tables
TABLE 1. CHOLERA VACCINES MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
TABLE 3. GLOBAL CHOLERA VACCINES MARKET SIZE, 2018-2023 (USD MILLION)
TABLE 4. GLOBAL CHOLERA VACCINES MARKET SIZE, 2024-2030 (USD MILLION)
TABLE 5. GLOBAL CHOLERA VACCINES MARKET SIZE, BY REGION, 2018-2023 (USD MILLION)
TABLE 6. GLOBAL CHOLERA VACCINES MARKET SIZE, BY REGION, 2024-2030 (USD MILLION)
TABLE 7. GLOBAL CHOLERA VACCINES MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 8. GLOBAL CHOLERA VACCINES MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 9. GLOBAL CHOLERA VACCINES MARKET SIZE, BY INACTIVATED VACCINE, BY REGION, 2018-2023 (USD MILLION)
TABLE 10. GLOBAL CHOLERA VACCINES MARKET SIZE, BY INACTIVATED VACCINE, BY REGION, 2024-2030 (USD MILLION)
TABLE 11. GLOBAL CHOLERA VACCINES MARKET SIZE, BY LIVE ATTENUATED VACCINE, BY REGION, 2018-2023 (USD MILLION)
TABLE 12. GLOBAL CHOLERA VACCINES MARKET SIZE, BY LIVE ATTENUATED VACCINE, BY REGION, 2024-2030 (USD MILLION)
TABLE 13. GLOBAL CHOLERA VACCINES MARKET SIZE, BY METHOD OF ADMINISTRATION, 2018-2023 (USD MILLION)
TABLE 14. GLOBAL CHOLERA VACCINES MARKET SIZE, BY METHOD OF ADMINISTRATION, 2024-2030 (USD MILLION)
TABLE 15. GLOBAL CHOLERA VACCINES MARKET SIZE, BY INJECTABLE VACCINES, BY REGION, 2018-2023 (USD MILLION)
TABLE 16. GLOBAL CHOLERA VACCINES MARKET SIZE, BY INJECTABLE VACCINES, BY REGION, 2024-2030 (USD MILLION)
TABLE 17. GLOBAL CHOLERA VACCINES MARKET SIZE, BY ORAL VACCINES, BY REGION, 2018-2023 (USD MILLION)
TABLE 18. GLOBAL CHOLERA VACCINES MARKET SIZE, BY ORAL VACCINES, BY REGION, 2024-2030 (USD MILLION)
TABLE 19. GLOBAL CHOLERA VACCINES MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
TABLE 20. GLOBAL CHOLERA VACCINES MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
TABLE 21. GLOBAL CHOLERA VACCINES MARKET SIZE, BY GOVERNMENT VACCINATION PROGRAMS, BY REGION, 2018-2023 (USD MILLION)
TABLE 22. GLOBAL CHOLERA VACCINES MARKET SIZE, BY GOVERNMENT VACCINATION PROGRAMS, BY REGION, 2024-2030 (USD MILLION)
TABLE 23. GLOBAL CHOLERA VACCINES MARKET SIZE, BY HOSPITALS & CLINICS, BY REGION, 2018-2023 (USD MILLION)
TABLE 24. GLOBAL CHOLERA VACCINES MARKET SIZE, BY HOSPITALS & CLINICS, BY REGION, 2024-2030 (USD MILLION)
TABLE 25. GLOBAL CHOLERA VACCINES MARKET SIZE, BY AGE GROUP, 2018-2023 (USD MILLION)
TABLE 26. GLOBAL CHOLERA VACCINES MARKET SIZE, BY AGE GROUP, 2024-2030 (USD MILLION)
TABLE 27. GLOBAL CHOLERA VACCINES MARKET SIZE, BY ADULTS, BY REGION, 2018-2023 (USD MILLION)
TABLE 28. GLOBAL CHOLERA VACCINES MARKET SIZE, BY ADULTS, BY REGION, 2024-2030 (USD MILLION)
TABLE 29. GLOBAL CHOLERA VACCINES MARKET SIZE, BY CHILDREN, BY REGION, 2018-2023 (USD MILLION)
TABLE 30. GLOBAL CHOLERA VACCINES MARKET SIZE, BY CHILDREN, BY REGION, 2024-2030 (USD MILLION)
TABLE 31. AMERICAS CHOLERA VACCINES MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 32. AMERICAS CHOLERA VACCINES MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 33. AMERICAS CHOLERA VACCINES MARKET SIZE, BY METHOD OF ADMINISTRATION, 2018-2023 (USD MILLION)
TABLE 34. AMERICAS CHOLERA VACCINES MARKET SIZE, BY METHOD OF ADMINISTRATION, 2024-2030 (USD MILLION)
TABLE 35. AMERICAS CHOLERA VACCINES MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
TABLE 36. AMERICAS CHOLERA VACCINES MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
TABLE 37. AMERICAS CHOLERA VACCINES MARKET SIZE, BY AGE GROUP, 2018-2023 (USD MILLION)
TABLE 38. AMERICAS CHOLERA VACCINES MARKET SIZE, BY AGE GROUP, 2024-2030 (USD MILLION)
TABLE 39. AMERICAS CHOLERA VACCINES MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
TABLE 40. AMERICAS CHOLERA VACCINES MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
TABLE 41. ARGENTINA CHOLERA VACCINES MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 42. ARGENTINA CHOLERA VACCINES MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 43. ARGENTINA CHOLERA VACCINES MARKET SIZE, BY METHOD OF ADMINISTRATION, 2018-2023 (USD MILLION)
TABLE 44. ARGENTINA CHOLERA VACCINES MARKET SIZE, BY METHOD OF ADMINISTRATION, 2024-2030 (USD MILLION)
TABLE 45. ARGENTINA CHOLERA VACCINES MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
TABLE 46. ARGENTINA CHOLERA VACCINES MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
TABLE 47. ARGENTINA CHOLERA VACCINES MARKET SIZE, BY AGE GROUP, 2018-2023 (USD MILLION)
TABLE 48. ARGENTINA CHOLERA VACCINES MARKET SIZE, BY AGE GROUP, 2024-2030 (USD MILLION)
TABLE 49. BRAZIL CHOLERA VACCINES MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 50. BRAZIL CHOLERA VACCINES MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 51. BRAZIL CHOLERA VACCINES MARKET SIZE, BY METHOD OF ADMINISTRATION, 2018-2023 (USD MILLION)
TABLE 52. BRAZIL CHOLERA VACCINES MARKET SIZE, BY METHOD OF ADMINISTRATION, 2024-2030 (USD MILLION)
TABLE 53. BRAZIL CHOLERA VACCINES MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
TABLE 54. BRAZIL CHOLERA VACCINES MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
TABLE 55. BRAZIL CHOLERA VACCINES MARKET SIZE, BY AGE GROUP, 2018-2023 (USD MILLION)
TABLE 56. BRAZIL CHOLERA VACCINES MARKET SIZE, BY AGE GROUP, 2024-2030 (USD MILLION)
TABLE 57. CANADA CHOLERA VACCINES MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 58. CANADA CHOLERA VACCINES MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 59. CANADA CHOLERA VACCINES MARKET SIZE, BY METHOD OF ADMINISTRATION, 2018-2023 (USD MILLION)
TABLE 60. CANADA CHOLERA VACCINES MARKET SIZE, BY METHOD OF ADMINISTRATION, 2024-2030 (USD MILLION)
TABLE 61. CANADA CHOLERA VACCINES MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
TABLE 62. CANADA CHOLERA VACCINES MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
TABLE 63. CANADA CHOLERA VACCINES MARKET SIZE, BY AGE GROUP, 2018-2023 (USD MILLION)
TABLE 64. CANADA CHOLERA VACCINES MARKET SIZE, BY AGE GROUP, 2024-2030 (USD MILLION)
TABLE 65. MEXICO CHOLERA VACCINES MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 66. MEXICO CHOLERA VACCINES MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 67. MEXICO CHOLERA VACCINES MARKET SIZE, BY METHOD OF ADMINISTRATION, 2018-2023 (USD MILLION)
TABLE 68. MEXICO CHOLERA VACCINES MARKET SIZE, BY METHOD OF ADMINISTRATION, 2024-2030 (USD MILLION)
TABLE 69. MEXICO CHOLERA VACCINES MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
TABLE 70. MEXICO CHOLERA VACCINES MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
TABLE 71. MEXICO CHOLERA VACCINES MARKET SIZE, BY AGE GROUP, 2018-2023 (USD MILLION)
TABLE 72. MEXICO CHOLERA VACCINES MARKET SIZE, BY AGE GROUP, 2024-2030 (USD MILLION)
TABLE 73. UNITED STATES CHOLERA VACCINES MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 74. UNITED STATES CHOLERA VACCINES MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 75. UNITED STATES CHOLERA VACCINES MARKET SIZE, BY METHOD OF ADMINISTRATION, 2018-2023 (USD MILLION)
TABLE 76. UNITED STATES CHOLERA VACCINES MARKET SIZE, BY METHOD OF ADMINISTRATION, 2024-2030 (USD MILLION)
TABLE 77. UNITED STATES CHOLERA VACCINES MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
TABLE 78. UNITED STATES CHOLERA VACCINES MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
TABLE 79. UNITED STATES CHOLERA VACCINES MARKET SIZE, BY AGE GROUP, 2018-2023 (USD MILLION)
TABLE 80. UNITED STATES CHOLERA VACCINES MARKET SIZE, BY AGE GROUP, 2024-2030 (USD MILLION)
TABLE 81. UNITED STATES CHOLERA VACCINES MARKET SIZE, BY STATE, 2018-2023 (USD MILLION)
TABLE 82. UNITED STATES CHOLERA VACCINES MARKET SIZE, BY STATE, 2024-2030 (USD MILLION)
TABLE 83. ASIA-PACIFIC CHOLERA VACCINES MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 84. ASIA-PACIFIC CHOLERA VACCINES MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 85. ASIA-PACIFIC CHOLERA VACCINES MARKET SIZE, BY METHOD OF ADMINISTRATION, 2018-2023 (USD MILLION)
TABLE 86. ASIA-PACIFIC CHOLERA VACCINES MARKET SIZE, BY METHOD OF ADMINISTRATION, 2024-2030 (USD MILLION)
TABLE 87. ASIA-PACIFIC CHOLERA VACCINES MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
TABLE 88. ASIA-PACIFIC CHOLERA VACCINES MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
TABLE 89. ASIA-PACIFIC CHOLERA VACCINES MARKET SIZE, BY AGE GROUP, 2018-2023 (USD MILLION)
TABLE 90. ASIA-PACIFIC CHOLERA VACCINES MARKET SIZE, BY AGE GROUP, 2024-2030 (USD MILLION)
TABLE 91. ASIA-PACIFIC CHOLERA VACCINES MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
TABLE 92. ASIA-PACIFIC CHOLERA VACCINES MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
TABLE 93. AUSTRALIA CHOLERA VACCINES MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 94. AUSTRALIA CHOLERA VACCINES MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 95. AUSTRALIA CHOLERA VACCINES MARKET SIZE, BY METHOD OF ADMINISTRATION, 2018-2023 (USD MILLION)
TABLE 96. AUSTRALIA CHOLERA VACCINES MARKET SIZE, BY METHOD OF ADMINISTRATION, 2024-2030 (USD MILLION)
TABLE 97. AUSTRALIA CHOLERA VACCINES MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
TABLE 98. AUSTRALIA CHOLERA VACCINES MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
TABLE 99. AUSTRALIA CHOLERA VACCINES MARKET SIZE, BY AGE GROUP, 2018-2023 (USD MILLION)
TABLE 100. AUSTRALIA CHOLERA VACCINES MARKET SIZE, BY AGE GROUP, 2024-2030 (USD MILLION)
TABLE 101. CHINA CHOLERA VACCINES MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 102. CHINA CHOLERA VACCINES MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 103. CHINA CHOLERA VACCINES MARKET SIZE, BY METHOD OF ADMINISTRATION, 2018-2023 (USD MILLION)
TABLE 104. CHINA CHOLERA VACCINES MARKET SIZE, BY METHOD OF ADMINISTRATION, 2024-2030 (USD MILLION)
TABLE 105. CHINA CHOLERA VACCINES MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
TABLE 106. CHINA CHOLERA VACCINES MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
TABLE 107. CHINA CHOLERA VACCINES MARKET SIZE, BY AGE GROUP, 2018-2023 (USD MILLION)
TABLE 108. CHINA CHOLERA VACCINES MARKET SIZE, BY AGE GROUP, 2024-2030 (USD MILLION)
TABLE 109. INDIA CHOLERA VACCINES MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 110. INDIA CHOLERA VACCINES MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 111. INDIA CHOLERA VACCINES MARKET SIZE, BY METHOD OF ADMINISTRATION, 2018-2023 (USD MILLION)
TABLE 112. INDIA CHOLERA VACCINES MARKET SIZE, BY METHOD OF ADMINISTRATION, 2024-2030 (USD MILLION)
TABLE 113. INDIA CHOLERA VACCINES MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
TABLE 114. INDIA CHOLERA VACCINES MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
TABLE 115. INDIA CHOLERA VACCINES MARKET SIZE, BY AGE GROUP, 2018-2023 (USD MILLION)
TABLE 116. INDIA CHOLERA VACCINES MARKET SIZE, BY AGE GROUP, 2024-2030 (USD MILLION)
TABLE 117. INDONESIA CHOLERA VACCINES MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 118. INDONESIA CHOLERA VACCINES MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 119. INDONESIA CHOLERA VACCINES MARKET SIZE, BY METHOD OF ADMINISTRATION, 2018-2023 (USD MILLION)
TABLE 120. INDONESIA CHOLERA VACCINES MARKET SIZE, BY METHOD OF ADMINISTRATION, 2024-2030 (USD MILLION)
TABLE 121. INDONESIA CHOLERA VACCINES MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
TABLE 122. INDONESIA CHOLERA VACCINES MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
TABLE 123. INDONESIA CHOLERA VACCINES MARKET SIZE, BY AGE GROUP, 2018-2023 (USD MILLION)
TABLE 124. INDONESIA CHOLERA VACCINES MARKET SIZE, BY AGE GROUP, 2024-2030 (USD MILLION)
TABLE 125. JAPAN CHOLERA VACCINES MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 126. JAPAN CHOLERA VACCINES MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 127. JAPAN CHOLERA VACCINES MARKET SIZE, BY METHOD OF ADMINISTRATION, 2018-2023 (USD MILLION)
TABLE 128. JAPAN CHOLERA VACCINES MARKET SIZE, BY METHOD OF ADMINISTRATION, 2024-2030 (USD MILLION)
TABLE 129. JAPAN CHOLERA VACCINES MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
TABLE 130. JAPAN CHOLERA VACCINES MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
TABLE 131. JAPAN CHOLERA VACCINES MARKET SIZE, BY AGE GROUP, 2018-2023 (USD MILLION)
TABLE 132. JAPAN CHOLERA VACCINES MARKET SIZE, BY AGE GROUP, 2024-2030 (USD MILLION)
TABLE 133. MALAYSIA CHOLERA VACCINES MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 134. MALAYSIA CHOLERA VACCINES MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 135. MALAYSIA CHOLERA VACCINES MARKET SIZE, BY METHOD OF ADMINISTRATION, 2018-2023 (USD MILLION)
TABLE 136. MALAYSIA CHOLERA VACCINES MARKET SIZE, BY METHOD OF ADMINISTRATION, 2024-2030 (USD MILLION)
TABLE 137. MALAYSIA CHOLERA VACCINES MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
TABLE 138. MALAYSIA CHOLERA VACCINES MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
TABLE 139. MALAYSIA CHOLERA VACCINES MARKET SIZE, BY AGE GROUP, 2018-2023 (USD MILLION)
TABLE 140. MALAYSIA CHOLERA VACCINES MARKET SIZE, BY AGE GROUP, 2024-2030 (USD MILLION)
TABLE 141. PHILIPPINES CHOLERA VACCINES MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 142. PHILIPPINES CHOLERA VACCINES MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 143. PHILIPPINES CHOLERA VACCINES MARKET SIZE, BY METHOD OF ADMINISTRATION, 2018-2023 (USD MILLION)
TABLE 144. PHILIPPINES CHOLERA VACCINES MARKET SIZE, BY METHOD OF ADMINISTRATION, 2024-2030 (USD MILLION)
TABLE 145. PHILIPPINES CHOLERA VACCINES MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
TABLE 146. PHILIPPINES CHOLERA VACCINES MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
TABLE 147. PHILIPPINES CHOLERA VACCINES MARKET SIZE, BY AGE GROUP, 2018-2023 (USD MILLION)
TABLE 148. PHILIPPINES CHOLERA VACCINES MARKET SIZE, BY AGE GROUP, 2024-2030 (USD MILLION)
TABLE 149. SINGAPORE CHOLERA VACCINES MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 150. SINGAPORE CHOLERA VACCINES MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 151. SINGAPORE CHOLERA VACCINES MARKET SIZE, BY METHOD OF ADMINISTRATION, 2018-2023 (USD MILLION)
TABLE 152. SINGAPORE CHOLERA VACCINES MARKET SIZE, BY METHOD OF ADMINISTRATION, 2024-2030 (USD MILLION)
TABLE 153. SINGAPORE CHOLERA VACCINES MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
TABLE 154. SINGAPORE CHOLERA VACCINES MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
TABLE 155. SINGAPORE CHOLERA VACCINES MARKET SIZE, BY AGE GROUP, 2018-2023 (USD MILLION)
TABLE 156. SINGAPORE CHOLERA VACCINES MARKET SIZE, BY AGE GROUP, 2024-2030 (USD MILLION)
TABLE 157. SOUTH KOREA CHOLERA VACCINES MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 158. SOUTH KOREA CHOLERA VACCINES MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 159. SOUTH KOREA CHOLERA VACCINES MARKET SIZE, BY METHOD OF ADMINISTRATION, 2018-2023 (USD MILLION)
TABLE 160. SOUTH KOREA CHOLERA VACCINES MARKET SIZE, BY METHOD OF ADMINISTRATION, 2024-2030 (USD MILLION)
TABLE 161. SOUTH KOREA CHOLERA VACCINES MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
TABLE 162. SOUTH KOREA CHOLERA VACCINES MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
TABLE 163. SOUTH KOREA CHOLERA VACCINES MARKET SIZE, BY AGE GROUP, 2018-2023 (USD MILLION)
TABLE 164. SOUTH KOREA CHOLERA VACCINES MARKET SIZE, BY AGE GROUP, 2024-2030 (USD MILLION)
TABLE 165. TAIWAN CHOLERA VACCINES MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 166. TAIWAN CHOLERA VACCINES MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 167. TAIWAN CHOLERA VACCINES MARKET SIZE, BY METHOD OF ADMINISTRATION, 2018-2023 (USD MILLION)
TABLE 168. TAIWAN CHOLERA VACCINES MARKET SIZE, BY METHOD OF ADMINISTRATION, 2024-2030 (USD MILLION)
TABLE 169. TAIWAN CHOLERA VACCINES MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
TABLE 170. TAIWAN CHOLERA VACCINES MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
TABLE 171. TAIWAN CHOLERA VACCINES MARKET SIZE, BY AGE GROUP, 2018-2023 (USD MILLION)
TABLE 172. TAIWAN CHOLERA VACCINES MARKET SIZE, BY AGE GROUP, 2024-2030 (USD MILLION)
TABLE 173. THAILAND CHOLERA VACCINES MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 174. THAILAND CHOLERA VACCINES MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 175. THAILAND CHOLERA VACCINES MARKET SIZE, BY METHOD OF ADMINISTRATION, 2018-2023 (USD MILLION)
TABLE 176. THAILAND CHOLERA VACCINES MARKET SIZE, BY METHOD OF ADMINISTRATION, 2024-2030 (USD MILLION)
TABLE 177. THAILAND CHOLERA VACCINES MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
TABLE 178. THAILAND CHOLERA VACCINES MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
TABLE 179. THAILAND CHOLERA VACCINES MARKET SIZE, BY AGE GROUP, 2018-2023 (USD MILLION)
TABLE 180. THAILAND CHOLERA VACCINES MARKET SIZE, BY AGE GROUP, 2024-2030 (USD MILLION)
TABLE 181. VIETNAM CHOLERA VACCINES MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 182. VIETNAM CHOLERA VACCINES MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 183. VIETNAM CHOLERA VACCINES MARKET SIZE, BY METHOD OF ADMINISTRATION, 2018-2023 (USD MILLION)
TABLE 184. VIETNAM CHOLERA VACCINES MARKET SIZE, BY METHOD OF ADMINISTRATION, 2024-2030 (USD MILLION)
TABLE 185. VIETNAM CHOLERA VACCINES MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
TABLE 186. VIETNAM CHOLERA VACCINES MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
TABLE 187. VIETNAM CHOLERA VACCINES MARKET SIZE, BY AGE GROUP, 2018-2023 (USD MILLION)
TABLE 188. VIETNAM CHOLERA VACCINES MARKET SIZE, BY AGE GROUP, 2024-2030 (USD MILLION)
TABLE 189. EUROPE, MIDDLE EAST & AFRICA CHOLERA VACCINES MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 190. EUROPE, MIDDLE EAST & AFRICA CHOLERA VACCINES MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 191. EUROPE, MIDDLE EAST & AFRICA CHOLERA VACCINES MARKET SIZE, BY METHOD OF ADMINISTRATION, 2018-2023 (USD MILLION)
TABLE 192. EUROPE, MIDDLE EAST & AFRICA CHOLERA VACCINES MARKET SIZE, BY METHOD OF ADMINISTRATION, 2024-2030 (USD MILLION)
TABLE 193. EUROPE, MIDDLE EAST & AFRICA CHOLERA VACCINES MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
TABLE 194. EUROPE, MIDDLE EAST & AFRICA CHOLERA VACCINES MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
TABLE 195. EUROPE, MIDDLE EAST & AFRICA CHOLERA VACCINES MARKET SIZE, BY AGE GROUP, 2018-2023 (USD MILLION)
TABLE 196. EUROPE, MIDDLE EAST & AFRICA CHOLERA VACCINES MARKET SIZE, BY AGE GROUP, 2024-2030 (USD MILLION)
TABLE 197. EUROPE, MIDDLE EAST & AFRICA CHOLERA VACCINES MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
TABLE 198. EUROPE, MIDDLE EAST & AFRICA CHOLERA VACCINES MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
TABLE 199. DENMARK CHOLERA VACCINES MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 200. DENMARK CHOLERA VACCINES MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 201. DENMARK CHOLERA VACCINES MARKET SIZE, BY METHOD OF ADMINISTRATION, 2018-2023 (USD MILLION)
TABLE 202. DENMARK CHOLERA VACCINES MARKET SIZE, BY METHOD OF ADMINISTRATION, 2024-2030 (USD MILLION)
TABLE 203. DENMARK CHOLERA VACCINES MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
TABLE 204. DENMARK CHOLERA VACCINES MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
TABLE 205. DENMARK CHOLERA VACCINES MARKET SIZE, BY AGE GROUP, 2018-2023 (USD MILLION)
TABLE 206. DENMARK CHOLERA VACCINES MARKET SIZE, BY AGE GROUP, 2024-2030 (USD MILLION)
TABLE 207. EGYPT CHOLERA VACCINES MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 208. EGYPT CHOLERA VACCINES MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 209. EGYPT CHOLERA VACCINES MARKET SIZE, BY METHOD OF ADMINISTRATION, 2018-2023 (USD MILLION)
TABLE 210. EGYPT CHOLERA VACCINES MARKET SIZE, BY METHOD OF ADMINISTRATION, 2024-2030 (USD MILLION)
TABLE 211. EGYPT CHOLERA VACCINES MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
TABLE 212. EGYPT CHOLERA VACCINES MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
TABLE 213. EGYPT CHOLERA VACCINES MARKET SIZE, BY AGE GROUP, 2018-2023 (USD MILLION)
TABLE 214. EGYPT CHOLERA VACCINES MARKET SIZE, BY AGE GROUP, 2024-2030 (USD MILLION)
TABLE 215. FINLAND CHOLERA VACCINES MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 216. FINLAND CHOLERA VACCINES MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 217. FINLAND CHOLERA VACCINES MARKET SIZE, BY METHOD OF ADMINISTRATION, 2018-2023 (USD MILLION)
TABLE 218. FINLAND CHOLERA VACCINES MARKET SIZE, BY METHOD OF ADMINISTRATION, 2024-2030 (USD MILLION)
TABLE 219. FINLAND CHOLERA VACCINES MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
TABLE 220. FINLAND CHOLERA VACCINES MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
TABLE 221. FINLAND CHOLERA VACCINES MARKET SIZE, BY AGE GROUP, 2018-2023 (USD MILLION)
TABLE 222. FINLAND CHOLERA VACCINES MARKET SIZE, BY AGE GROUP, 2024-2030 (USD MILLION)
TABLE 223. FRANCE CHOLERA VACCINES MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 224. FRANCE CHOLERA VACCINES MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 225. FRANCE CHOLERA VACCINES MARKET SIZE, BY METHOD OF ADMINISTRATION, 2018-2023 (USD MILLION)
TABLE 226. FRANCE CHOLERA VACCINES MARKET SIZE, BY METHOD OF ADMINISTRATION, 2024-2030 (USD MILLION)
TABLE 227. FRANCE CHOLERA VACCINES MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
TABLE 228. FRANCE CHOLERA VACCINES MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
TABLE 229. FRANCE CHOLERA VACCINES MARKET SIZE, BY AGE GROUP, 2018-2023 (USD MILLION)
TABLE 230. FRANCE CHOLERA VACCINES MARKET SIZE, BY AGE GROUP, 2024-2030 (USD MILLION)
TABLE 231. GERMANY CHOLERA VACCINES MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 232. GERMANY CHOLERA VACCINES MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 233. GERMANY CHOLERA VACCINES MARKET SIZE, BY METHOD OF ADMINISTRATION, 2018-2023 (USD MILLION)
TABLE 234. GERMANY CHOLERA VACCINES MARKET SIZE, BY METHOD OF ADMINISTRATION, 2024-2030 (USD MILLION)
TABLE 235. GERMANY CHOLERA VACCINES MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
TABLE 236. GERMANY CHOLERA VACCINES MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
TABLE 237. GERMANY CHOLERA VACCINES MARKET SIZE, BY AGE GROUP, 2018-2023 (USD MILLION)
TABLE 238. GERMANY CHOLERA VACCINES MARKET SIZE, BY AGE GROUP, 2024-2030 (USD MILLION)
TABLE 239. ISRAEL CHOLERA VACCINES MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 240. ISRAEL CHOLERA VACCINES MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 241. ISRAEL CHOLERA VACCINES MARKET SIZE, BY METHOD OF ADMINISTRATION, 2018-2023 (USD MILLION)
TABLE 242. ISRAEL CHOLERA VACCINES MARKET SIZE, BY METHOD OF ADMINISTRATION, 2024-2030 (USD MILLION)
TABLE 243. ISRAEL CHOLERA VACCINES MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
TABLE 244. ISRAEL CHOLERA VACCINES MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
TABLE 245. ISRAEL CHOLERA VACCINES MARKET SIZE, BY AGE GROUP, 2018-2023 (USD MILLION)
TABLE 246. ISRAEL CHOLERA VACCINES MARKET SIZE, BY AGE GROUP, 2024-2030 (USD MILLION)
TABLE 247. ITALY CHOLERA VACCINES MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 248. ITALY CHOLERA VACCINES MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 249. ITALY CHOLERA VACCINES MARKET SIZE, BY METHOD OF ADMINISTRATION, 2018-2023 (USD MILLION)
TABLE 250. ITALY CHOLERA VACCINES MARKET SIZE, BY METHOD OF ADMINISTRATION, 2024-2030 (USD MILLION)
TABLE 251. ITALY CHOLERA VACCINES MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
TABLE 252. ITALY CHOLERA VACCINES MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
TABLE 253. ITALY CHOLERA VACCINES MARKET SIZE, BY AGE GROUP, 2018-2023 (USD MILLION)
TABLE 254. ITALY CHOLERA VACCINES MARKET SIZE, BY AGE GROUP, 2024-2030 (USD MILLION)
TABLE 255. NETHERLANDS CHOLERA VACCINES MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 256. NETHERLANDS CHOLERA VACCINES MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 257. NETHERLANDS CHOLERA VACCINES MARKET SIZE, BY METHOD OF ADMINISTRATION, 2018-2023 (USD MILLION)
TABLE 258. NETHERLANDS CHOLERA VACCINES MARKET SIZE, BY METHOD OF ADMINISTRATION, 2024-2030 (USD MILLION)
TABLE 259. NETHERLANDS CHOLERA VACCINES MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
TABLE 260. NETHERLANDS CHOLERA VACCINES MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
TABLE 261. NETHERLANDS CHOLERA VACCINES MARKET SIZE, BY AGE GROUP, 2018-2023 (USD MILLION)
TABLE 262. NETHERLANDS CHOLERA VACCINES MARKET SIZE, BY AGE GROUP, 2024-2030 (USD MILLION)
TABLE 263. NIGERIA CHOLERA VACCINES MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 264. NIGERIA CHOLERA VACCINES MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 265. NIGERIA CHOLERA VACCINES MARKET SIZE, BY METHOD OF ADMINISTRATION, 2018-2023 (USD MILLION)
TABLE 266. NIGERIA CHOLERA VACCINES MARKET SIZE, BY METHOD OF ADMINISTRATION, 2024-2030 (USD MILLION)
TABLE 267. NIGERIA CHOLERA VACCINES MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
TABLE 268. NIGERIA CHOLERA VACCINES MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
TABLE 269. NIGERIA CHOLERA VACCINES MARKET SIZE, BY AGE GROUP, 2018-2023 (USD MILLION)
TABLE 270. NIGERIA CHOLERA VACCINES MARKET SIZE, BY AGE GROUP, 2024-2030 (USD MILLION)
TABLE 271. NORWAY CHOLERA VACCINES MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 272. NORWAY CHOLERA VACCINES MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 273. NORWAY CHOLERA VACCINES MARKET SIZE, BY METHOD OF ADMINISTRATION, 2018-2023 (USD MILLION)
TABLE 274. NORWAY CHOLERA VACCINES MARKET SIZE, BY METHOD OF ADMINISTRATION, 2024-2030 (USD MILLION)
TABLE 275. NORWAY CHOLERA VACCINES MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
TABLE 276. NORWAY CHOLERA VACCINES MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
TABLE 277. NORWAY CHOLERA VACCINES MARKET SIZE, BY AGE GROUP, 2018-2023 (USD MILLION)
TABLE 278. NORWAY CHOLERA VACCINES MARKET SIZE, BY AGE GROUP, 2024-2030 (USD MILLION)
TABLE 279. POLAND CHOLERA VACCINES MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 280. POLAND CHOLERA VACCINES MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 281. POLAND CHOLERA VACCINES MARKET SIZE, BY METHOD OF ADMINISTRATION, 2018-2023 (USD MILLION)
TABLE 282. POLAND CHOLERA VACCINES MARKET SIZE, BY METHOD OF ADMINISTRATION, 2024-2030 (USD MILLION)
TABLE 283. POLAND CHOLERA VACCINES MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
TABLE 284. POLAND CHOLERA VACCINES MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
TABLE 285. POLAND CHOLERA VACCINES MARKET SIZE, BY AGE GROUP, 2018-2023 (USD MILLION)
TABLE 286. POLAND CHOLERA VACCINES MARKET SIZE, BY AGE GROUP, 2024-2030 (USD MILLION)
TABLE 287. QATAR CHOLERA VACCINES MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 288. QATAR CHOLERA VACCINES MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 289. QATAR CHOLERA VACCINES MARKET SIZE, BY METHOD OF ADMINISTRATION, 2018-2023 (USD MILLION)
TABLE 290. QATAR CHOLERA VACCINES MARKET SIZE, BY METHOD OF ADMINISTRATION, 2024-2030 (USD MILLION)
TABLE 291. QATAR CHOLERA VACCINES MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
TABLE 292. QATAR CHOLERA VACCINES MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
TABLE 293. QATAR CHOLERA VACCINES MARKET SIZE, BY AGE GROUP, 2018-2023 (USD MILLION)
TABLE 294. QATAR CHOLERA VACCINES MARKET SIZE, BY AGE GROUP, 2024-2030 (USD MILLION)
TABLE 295. RUSSIA CHOLERA VACCINES MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 296. RUSSIA CHOLERA VACCINES MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 297. RUSSIA CHOLERA VACCINES MARKET SIZE, BY METHOD OF ADMINISTRATION, 2018-2023 (USD MILLION)
TABLE 298. RUSSIA CHOLERA VACCINES MARKET SIZE, BY METHOD OF ADMINISTRATION, 2024-2030 (USD MILLION)
TABLE 299. RUSSIA CHOLERA VACCINES MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
TABLE 300. RUSSIA CHOLERA VACCINES MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
TABLE 301. RUSSIA CHOLERA VACCINES MARKET SIZE, BY AGE GROUP, 2018-2023 (USD MILLION)
TABLE 302. RUSSIA CHOLERA VACCINES MARKET SIZE, BY AGE GROUP, 2024-2030 (USD MILLION)
TABLE 303. SAUDI ARABIA CHOLERA VACCINES MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 304. SAUDI ARABIA CHOLERA VACCINES MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 305. SAUDI ARABIA CHOLERA VACCINES MARKET SIZE, BY METHOD OF ADMINISTRATION, 2018-2023 (USD MILLION)
TABLE 306. SAUDI ARABIA CHOLERA VACCINES MARKET SIZE, BY METHOD OF ADMINISTRATION, 2024-2030 (USD MILLION)
TABLE 307. SAUDI ARABIA CHOLERA VACCINES MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
TABLE 308. SAUDI ARABIA CHOLERA VACCINES MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
TABLE 309. SAUDI ARABIA CHOLERA VACCINES MARKET SIZE, BY AGE GROUP, 2018-2023 (USD MILLION)
TABLE 310. SAUDI ARABIA CHOLERA VACCINES MARKET SIZE, BY AGE GROUP, 2024-2030 (USD MILLION)
TABLE 311. SOUTH AFRICA CHOLERA VACCINES MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 312. SOUTH AFRICA CHOLERA VACCINES MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 313. SOUTH AFRICA CHOLERA VACCINES MARKET SIZE, BY METHOD OF ADMINISTRATION, 2018-2023 (USD MILLION)
TABLE 314. SOUTH AFRICA CHOLERA VACCINES MARKET SIZE, BY METHOD OF ADMINISTRATION, 2024-2030 (USD MILLION)
TABLE 315. SOUTH AFRICA CHOLERA VACCINES MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
TABLE 316. SOUTH AFRICA CHOLERA VACCINES MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
TABLE 317. SOUTH AFRICA CHOLERA VACCINES MARKET SIZE, BY AGE GROUP, 2018-2023 (USD MILLION)
TABLE 318. SOUTH AFRICA CHOLERA VACCINES MARKET SIZE, BY AGE GROUP, 2024-2030 (USD MILLION)
TABLE 319. SPAIN CHOLERA VACCINES MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 320. SPAIN CHOLERA VACCINES MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 321. SPAIN CHOLERA VACCINES MARKET SIZE, BY METHOD OF ADMINISTRATION, 2018-2023 (USD MILLION)
TABLE 322. SPAIN CHOLERA VACCINES MARKET SIZE, BY METHOD OF ADMINISTRATION, 2024-2030 (USD MILLION)
TABLE 323. SPAIN CHOLERA VACCINES MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
TABLE 324. SPAIN CHOLERA VACCINES MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
TABLE 325. SPAIN CHOLERA VACCINES MARKET SIZE, BY AGE GROUP, 2018-2023 (USD MILLION)
TABLE 326. SPAIN CHOLERA VACCINES MARKET SIZE, BY AGE GROUP, 2024-2030 (USD MILLION)
TABLE 327. SWEDEN CHOLERA VACCINES MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 328. SWEDEN CHOLERA VACCINES MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 329. SWEDEN CHOLERA VACCINES MARKET SIZE, BY METHOD OF ADMINISTRATION, 2018-2023 (USD MILLION)
TABLE 330. SWEDEN CHOLERA VACCINES MARKET SIZE, BY METHOD OF ADMINISTRATION, 2024-2030 (USD MILLION)
TABLE 331. SWEDEN CHOLERA VACCINES MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
TABLE 332. SWEDEN CHOLERA VACCINES MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
TABLE 333. SWEDEN CHOLERA VACCINES MARKET SIZE, BY AGE GROUP, 2018-2023 (USD MILLION)
TABLE 334. SWEDEN CHOLERA VACCINES MARKET SIZE, BY AGE GROUP, 2024-2030 (USD MILLION)
TABLE 335. SWITZERLAND CHOLERA VACCINES MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 336. SWITZERLAND CHOLERA VACCINES MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 337. SWITZERLAND CHOLERA VACCINES MARKET SIZE, BY METHOD OF ADMINISTRATION, 2018-2023 (USD MILLION)
TABLE 338. SWITZERLAND CHOLERA VACCINES MARKET SIZE, BY METHOD OF ADMINISTRATION, 2024-2030 (USD MILLION)
TABLE 339. SWITZERLAND CHOLERA VACCINES MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
TABLE 340. SWITZERLAND CHOLERA VACCINES MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
TABLE 341. SWITZERLAND CHOLERA VACCINES MARKET SIZE, BY AGE GROUP, 2018-2023 (USD MILLION)
TABLE 342. SWITZERLAND CHOLERA VACCINES MARKET SIZE, BY AGE GROUP, 2024-2030 (USD MILLION)
TABLE 343. TURKEY CHOLERA VACCINES MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 344. TURKEY CHOLERA VACCINES MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 345. TURKEY CHOLERA VACCINES MARKET SIZE, BY METHOD OF ADMINISTRATION, 2018-2023 (USD MILLION)
TABLE 346. TURKEY CHOLERA VACCINES MARKET SIZE, BY METHOD OF ADMINISTRATION, 2024-2030 (USD MILLION)
TABLE 347. TURKEY CHOLERA VACCINES MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
TABLE 348. TURKEY CHOLERA VACCINES MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
TABLE 349. TURKEY CHOLERA VACCINES MARKET SIZE, BY AGE GROUP, 2018-2023 (USD MILLION)
TABLE 350. TURKEY CHOLERA VACCINES MARKET SIZE, BY AGE GROUP, 2024-2030 (USD MILLION)
TABLE 351. UNITED ARAB EMIRATES CHOLERA VACCINES MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 352. UNITED ARAB EMIRATES CHOLERA VACCINES MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 353. UNITED ARAB EMIRATES CHOLERA VACCINES MARKET SIZE, BY METHOD OF ADMINISTRATION, 2018-2023 (USD MILLION)
TABLE 354. UNITED ARAB EMIRATES CHOLERA VACCINES MARKET SIZE, BY METHOD OF ADMINISTRATION, 2024-2030 (USD MILLION)
TABLE 355. UNITED ARAB EMIRATES CHOLERA VACCINES MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
TABLE 356. UNITED ARAB EMIRATES CHOLERA VACCINES MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
TABLE 357. UNITED ARAB EMIRATES CHOLERA VACCINES MARKET SIZE, BY AGE GROUP, 2018-2023 (USD MILLION)
TABLE 358. UNITED ARAB EMIRATES CHOLERA VACCINES MARKET SIZE, BY AGE GROUP, 2024-2030 (USD MILLION)
TABLE 359. UNITED KINGDOM CHOLERA VACCINES MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 360. UNITED KINGDOM CHOLERA VACCINES MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 361. UNITED KINGDOM CHOLERA VACCINES MARKET SIZE, BY METHOD OF ADMINISTRATION, 2018-2023 (USD MILLION)
TABLE 362. U

Companies Mentioned

  • Astellas Pharma Inc.
  • Beijing Minhai Biological Technology Co., Ltd.
  • Bharat Biotech Ltd.
  • Bio-Manguinhos
  • Biological E Ltd
  • BioVac by Ceva Santé Animale
  • Emergent BioSolutions Inc.
  • GlaxoSmithKline plc
  • Haffkine Bio-Pharmaceutical Corporation Ltd
  • Incepta Pharmaceuticals Ltd.
  • Merck & Co. Inc
  • Panacea Biotec Ltd
  • Sanofi S.A.
  • SK Inc.
  • Techinvention Lifecare Pvt. Ltd.
  • Valneva SE

Methodology

Loading
LOADING...

Table Information

Report AttributeDetails
No. of Pages191
PublishedMay 2024
Forecast Period2024 - 2030
Estimated Market Value ( USD ) in 2024 $ 307.02 Million
Forecasted Market Value ( USD ) by 2030 $ 469.83 Million
Compound Annual Growth Rate7.3%
Regions CoveredGlobal
No. of Companies Mentioned16

Related Topics

Related Reports

Global Cholera Vaccines Market Report by Vaccine Type, Product, End User, and Region 2024-2032 - Product Image

Global Cholera Vaccines Market Report by Vaccine Type, Product, End User, and Region 2024-2032

  • Report
  • 138 Pages
  • Global
From
Cholera Vaccine Global Market Insights 2023, Analysis and Forecast to 2028, by Market Participants, Regions, Technology, Application, Product Type - Product Image

Cholera Vaccine Global Market Insights 2023, Analysis and Forecast to 2028, by Market Participants, Regions, Technology, Application, Product Type

  • Report
  • 78 Pages
  • Global
From
Oral Cholera Vaccine Global Market Insights 2023, Analysis and Forecast to 2028, by Market Participants, Regions, Technology, Application, Product Type - Product Image

Oral Cholera Vaccine Global Market Insights 2023, Analysis and Forecast to 2028, by Market Participants, Regions, Technology, Application, Product Type

  • Report
  • 78 Pages
  • Global
From
Global Oral Vaccine Market by Type (Attenuated, Inactive), Application (Cholera, Polio, Rabies), End-User - Forecast 2024-2030 - Product Image

Global Oral Vaccine Market by Type (Attenuated, Inactive), Application (Cholera, Polio, Rabies), End-User - Forecast 2024-2030

  • Report
  • 196 Pages
  • Global
From
Global Vaccines Market by Type (Monovalent Vaccine, Multivalent Vaccine), Technology Type (Inactivated Vaccines, Live-Attenuated Vaccines, Messenger RNA (mRNA) Vaccines), Indication, Route of administration, Age Group - Forecast 2024-2030 - Product Image

Global Vaccines Market by Type (Monovalent Vaccine, Multivalent Vaccine), Technology Type (Inactivated Vaccines, Live-Attenuated Vaccines, Messenger RNA (mRNA) Vaccines), Indication, Route of administration, Age Group - Forecast 2024-2030

  • Report
  • 190 Pages
  • Global
From
Copyright © 2002-2024 Research and Markets. All Rights Reserved.